Match Document Document Title
6562846 Bisarylimidazolyl fatty acid amide hydrolase inhibitors  
The present invention relates to bisarylimidazolyl derivatives and pharmaceutical compositions comprising said compounds inhibiting fatty acid amide hydrolase and useful for the treatment of pain,...
6548520 Substituted imidazoles having anti-cancer and cytokine inhibitory activity  
The present invention is related to novel 2-alkyl substituted imidazoles of formula (I) useful for the treatment of CSBP kinase mediated diseases.
6548519 Pyridoxine and pyridoxal analogues: novel uses  
The invention provides pyridoxal and pyridoxine analogues, pharmaceutical compositions containing pyridoxine and pyridoxal analogues, and methods of administering pharmaceutical compositions...
6534503 Melanocortin receptor-3 ligands to treat sexual dysfunction  
Methods for treating sexual dysfunction, such as erectile dysfunction or sexual arousal disorder, with a compound having the generic formula X 1 —X 2 -(D)Phe-Arg-(D)Trp-X 3 . A particularly...
6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents  
The present invention relates to compounds of the formula wherein R 2 , R 3 , R 6 and A are defined as in the specification, to pharmaceutical compositions containing them and to their...
6531478 Amino pyrazole derivatives useful for the treatment of obesity and other disorders  
Amino pyrazole derivatives of the formula: which are ligands for the neuropeptide Y, subtype 5 receptor and pharmaceutical compositions containing an amino pyrazole derivative as the active...
6524603 Process and composition for the antiparasitic treatment of the surroundings of animals  
A pesticidal composition and anti-parasitic treatment using the same, wherein the composition includes, in a combined pesticidally effective amount (a) carbaryl and (b) a compound having the...
6525076 Selective factor Xa inhibitors  
Novel compounds, their salts and compositions related thereto having activity against mammalian factor Xa are disclosed. The compounds are useful in vitro or in vivo for preventing or treating...
6518257 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof  
To provide a composition having a steroid C 17,20 -lyase inhibitory activity and useful as an agent for the prophylaxis or treatment of prostatism and tumors such as breast cancer. A compound...
6517871 Bioenhanced formulations comprising eprosartan in oral solid dosage form  
This invention relates to bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous form, a process for its production, compositions containing the compound and methods...
6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists  
The present invention discloses novel substituted imidazole compounds which have either or dual histamine-H 1 and H 3 receptor antagonist activity as well as methods for preparing such compounds....
6514952 Hydantoin derivatives as inhibitors of leucocyte adhesion and as VLA-4 antagonists  
Compounds of the formula I in which B, D, E, R, W, Y, Z, b, c, d, e, f, g and have the meanings indicated in the claims, are inhibitors of the adhesion and migration of leucocytes and/or...
6514993 Serotonin 5-HT1A and dopamin D2 receptor ligands  
The present invention relates to a novel series of 4-phenylpiperazines, 4-phenylpiperidines and 4-phenyl-1,2,3,6-tetrahydropyridines compounds of general formula (I) wherein A is alkylene,...
6514966 Compounds for the treatment of obesity  
NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated...
6511981 Compositions and treatment for diabetic complications  
This invention is directed to methods, pharmaceutical compositions and kits comprising an aldose reductase inhibitor (ARI), a prodrug thereof or a pharmaceutically acceptable salt of said ARI or...
6511998 Pyrazole carboxamides useful for the treatment of obesity and other disorders  
Pyrazole carboxamide derivatives of the formula: which are ligands for the neuropeptide Y, subtype 5 receptor, and pharmaceutical compositions containing a pyrazole carboxamide derivative as the...
6511997 Aminopyrazole derivatives  
Aminopyrazole derivatives represented by formula (I), or salts thereof, wherein X 1 and X 2 are each a hydrogen atom or a halogen atom, or X 1 and X 2 may be united together to form a lower...
6509361 1,5-Diaryl substituted pyrazoles as p38 kinase inhibitors  
The present invention contemplates 1,5-diaryl-substituted pyrazole compounds that, inter alia, inhibit the activity of p38 MAP kinase. Also contemplated by the invention are processes for the...
6506779 Acetylene derivatives as anti-inflammatory/analgesic agents  
The present invention relates to compounds of the formula wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , X and Y are defined as in the specification, to pharmaceutical compositions containing them...
6498172 Prostaglandin agonists and their use to treat bone disorders  
This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such...
6495551 Substituted phenyloxazolidinones and their use as antibiotics  
The invention concerns compounds of formula (I), wherein, for example, R 1 is of the formula —NHC(═O)R a wherein R a is (1-4C)alkyl; R 2 and R 3 are independently hydrogen or fluoro; R...
6495550 Pyridine-substituted benzanilides as potassium ion channel openers  
The present invention provides a genus of pyridine-substituted benzanilides that are useful as openers of potassium ion channels. The compounds of the invention are of use in both therapeutic and...
6492397 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of arteriosclerosis  
A class of N-arylheteroarylalkyl imidazol-2-one compounds is described for use in treatment of arteriosclerosis. Compounds of particular interest are angiotensin II antagonists of Formula I: ...
6472397 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof  
The compounds represented by the formula (I), and pharmacologically acceptable salts and solvates thereof are disclosed. The compound is hydrolyzed in organisms into a compound represented by the...
6469040 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia  
This invention relates to the use of cyclooxygenase-2 inhibitors or derivatives thereof in preventing and treating neoplasia. In particular, the invention describes the method of preventing and...
6465493 Triarylimidazoles  
Compounds of formula (I) or a pharmaceutically acceptable salt thereof: wherein R 1 , R 2 and R 3 are various substituent groups; and one of X 1 and X 2 is N or CR′, and the other is NR′...
6465492 Heterocyclic compounds  
A heterocyclic compound has the following formula (I) wherein Y represents a substituted or unsubstituted ethylene group or a trimethylene group, W represents the group —SO 2 R 1 , X...
6462063 C-proteinase inhibitors  
The present invention relates to a novel class of N,N′-di substituted hydantoin hydroxamates capable of inhibiting C-proteinase, and to their use to regulate, modulate and/or inhibit abnormal...
6462069 Compounds, pharmaceutical compositions, and methods for inhibiting protein kinases  
Amino-pyrazole compounds that modulate and/or inhibit the activity of protein kinases. These compounds and pharmaceutical compositions containing them are capable of mediating and/or inhibiting the...
6458744 Pesticidal compounds and compositions  
The invention relates to 4-thiomethylpyrazole compounds of formula (I): wherein R 1 , R 2 , Q and n are as defined in the description, and to their use as pesticides.
6458813 Substituted pyridine compounds and methods of use  
Selected novel substituted pyridine compounds are effective for prophylaxis and treatment of diseases, such as TNF-α, IL-1β, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain...
6458789 2-aminopyridine derivatives and combinatorial libraries thereof  
The present invention relates to novel 2-aminopyridine derivative compounds of the following formula: wherein R 1 to R 5 have the meanings provided herein. The invention further relates to...
6455550 N-alkanoylphenylalanine derivatives  
Compounds of the formula: are disclosed which have activity as inhibitors of binding between VCAM-1 and cells expressing VLA-4. Such compounds are useful for treating diseases whose symptoms...
6444690 Insecticidal compositions  
The present invention relates to insecticidal mixtures of chloronicotinyl insecticides of the formula (I) in which R 1 represents C 1 -C 5 -alkyl, R 2 represents hydrogen or C 1 -C 5 -alkyl or...
6436962 Arylhydantoin derivatives and uses thereof  
Arylhydantoin derivatives and their pharmaceutically acceptable salts are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described....
6432988 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine  
The invention relates to 4-heteroaryl-5-phenylimidazole derivatives having 2-arylalkylthio, 2-arylalkenylthio and 2-arylalkynylthio substitution, of the general formula I: in which Ar is a...
6426341 Treatment for diabetic complications  
This invention is directed to methods, pharmaceutical compositions and kits comprising an aldose reductase inhibitor (ARI), a prodrug thereof or a pharmaceutically acceptable salt of said ARI or...
6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them  
The present invention relates to imidazolidine compounds of the formula I, The compounds of the formula I are valuable pharmaceutical active compounds, which are suitable, for example, for the...
6420384 Proton pump inhibitors  
Compounds and methods of treating or preventing bone disorders including osteoporosis, rheumatoid arthritis, and metastatic bone disease are provided. The inventive compounds comprise a bone...
6416752 Termite bait composition and method  
An improved termite bait composition comprises a powdered cellulosic attractant having a particle size in the range of approximately 1 to 100 micrometers and a termite killing agent. Also disclosed...
6417204 Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics  
The invention provides pyridoxal and pyridoxine analogues, pharmaceutical compositions containing pyridoxine and pyridoxal analogues, and methods of administering pharmaceutical compositions...
6410533 Antibacterial compounds  
The present invention provides compounds having useful antibacterial activity and pharmaceutical compositions comprising one or more of these compounds. The invention further relates to a method of...
6403630 Treating cancers associated with overexpression of HER-2/neu  
Cancers associated with overexpression of HER-2/neu are treated with a selective inhibitor of cyclooxygenase-2 as the sole treating agent or said inhibitor in combination regimen with HERCEPTIN®...
6403656 Use of ppar-&ggr activators in dermatology  
The invention concerns the use of at least one activator of receptors of the PPAR-γ type for preparing a pharmaceutical composition for treating skin disorders related to an anomaly of the...
6399606 Neuroprotective agents and methods related thereto  
Neuroprotective agents are disclosed having the following structure: wherein R 1 , R 2 , R 3 , R 4 and R 5 are as defined herein. Such compounds have utility in the treatment of conditions...
6387898 Treatment for CNS injuries  
This invention relates to a novel use of imidazole compounds in the treatment of CNS injuries.
6384061 Hydantoin compounds and methods related thereto  
The present invention relates to novel hydantoin compounds represented by formula (I) which shows an inhibitory activity against farnesyl transferase, and thus can be used as an anti-cancer agent,...
6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2  
Compounds of the formula wherein: X is selected from the group consisting of trihalomethyl, C 1 -C 6 alkyl, and a group of formula II: wherein: R 3 and R 4 are independently selected from...
6372765 Parasiticidal formulations that can be applied dermally  
The present invention relates to formulations for the dermal control of parasitic insects of animals, having the following composition agonists or antagonists of the nicotinergic acetylcholine...
6362192 2-(Pyrazolyloxy) -pyridin-3-ylacetic acid derivatives, agents containing the same and use thereof against noxious fungi and animal parasites  
Compounds of the formula I and salts thereof, in which the substituents and the index n have the following meanings: Q is —C(═CHCH 3 )—COOCH 3 , —C(═CHOCH 3 )—COOCH 3 , —C(═NOCH...